Skip to main content
SpringerLink
Log in

Nivolumab

Myasthenic syndrome: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cortellini A, et al. Immune Checkpoint Inhibitors and Myasthenic Syndromes: A Case Report of a Metastatic Renal Cell Carcinoma Patient Treated With Nivolumab. Journal of Clinical Neuromuscular Disease 20: 99-100, No. 2, Dec 2018. Available from: URL: http://doi.org/10.1097/CND.0000000000000220 - Italy

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nivolumab. Reactions Weekly 1769, 332 (2019). https://doi.org/10.1007/s40278-019-67346-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-67346-y

Search

Navigation